Myriad Genetics detects unauthorized network access, suspends testing and order systems
Myriad Genetics said it detected unauthorized access to its IT network on November 2, 2026, and temporarily suspended testing operations and order management systems while it investigates. The company said most systems have returned to normal, that it is still assessing whether any patient records were accessed, and that it does not believe the incident will have a material adverse effect on its business.
Key points
- Unauthorized access detected on November 2, 2026, within the company's IT network environment
- Testing operations and order management systems were temporarily suspended; most systems have since returned to normal operations
- Whether patient records were accessed is still under investigation; external experts have been engaged
- Company states it does not believe the incident will have a material adverse effect on its business
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.